Letermovir-d8
Product Specifications
Bioactivity
Letermovir-d8 is a deuterated compound of Letermovir. Letermovir has a CAS number of 917389-32-3. Letermovir (AIC246) is a novel anti-CMV compound (EC50: about 5 nM in fibroblast cells) . It targets the pUL56 subunit of the viral terminase complex.
Smiles
FC1=C2C(C(CC(O)=O)N(C3=C(OC)C=CC(C(F)(F)F)=C3)C(N4C([2H])([2H])C([2H])([2H])N(C5=CC(OC)=CC=C5)C([2H])([2H])C4([2H])[2H])=N2)=CC=C1
Molecular Formula
C29H20D8F4N4O4
Molecular Weight
580.6
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NBL1-15882 0.1 mg
14-3-3 sigma/Stratifin Overexpression Lysate (Native) - (Dry Ice)
Ask
View Details 
MBS2046996-01 0.1 mL
PE-Linked Polyclonal Antibody to Epidermal Growth Factor Receptor (EGFR)
Ask
View Details 
MBS2046996-02 0.2 mL
PE-Linked Polyclonal Antibody to Epidermal Growth Factor Receptor (EGFR)
Ask
View Details 
MBS2046996-03 0.5 mL
PE-Linked Polyclonal Antibody to Epidermal Growth Factor Receptor (EGFR)
Ask
View Details MBS2046996-04 1 mL
PE-Linked Polyclonal Antibody to Epidermal Growth Factor Receptor (EGFR)
Ask
View Details